Autoimmune neutropenia in adults

被引:63
作者
Akhtari, Mojtaba [1 ]
Curtis, Brian [2 ]
Waller, Edmund K. [1 ]
机构
[1] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Blood Ctr Wisconsin, Platelet & Neutrophil Immunol Lab, Milwaukee, WI USA
关键词
Neutropenia; Autoimmunity; G-CSF; ANTIBODIES; NEUTROPHILS; AUTOANTIBODIES; DEFICIENCY; INFECTION; DISEASE; SERA;
D O I
10.1016/j.autrev.2009.03.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune neutropenias (AIN) in adults are a heterogeneous group of diseases with clinical manifestations varying from being asymptomatic to having infectious complications with considerable morbidity and mortality. They are characterized by autoantibodies directed against neutrophils, resulting in destruction of neutrophils. AIN can be divided into two forms. In primary AIN, neutropenia is usually the sole hematologic abnormality and it is more common in children. Secondary AIN, which is more prevalent in adults, is associated with underlying autoimmune diseases, malignancies, infections, particularly viral, neurological diseases or drug exposure. This article is an overview of these conditions with emphasis on secondary AIN; it also discusses the available serological methods for antibody detection and recent therapeutic developments including colony stimulating factors, rituximab and Campath-1H. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 39 条
[11]  
Coppo Paul, 2004, Eur J Intern Med, V15, P451, DOI 10.1016/j.ejim.2004.08.009
[12]  
DEGOS L, 1982, BLOOD, V60, P968
[13]   The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood [J].
Deutsch, M ;
Tsopanou, E ;
Dourakis, SP .
CLINICAL RHEUMATOLOGY, 2004, 23 (01) :43-44
[14]   Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology [J].
Dungarwalla, M. ;
Marsh, J. C. W. ;
Tooze, J. A. ;
Lucas, G. ;
Ouwehand, W. ;
Pettengell, R. ;
Dearden, C. E. ;
Smith, E. C. Gordon ;
Elebute, M. O. .
ANNALS OF HEMATOLOGY, 2007, 86 (03) :191-197
[15]   Primary chronic autoimmune neutropenia successfully treated with sirolimus [J].
Ghnaya, H. ;
Bekov, K. ;
Jira, M. ;
Kettaneh, A. ;
Mejri, O. ;
Tiev, K. P. ;
Gain, M. ;
Cabane, J. .
REVUE DE MEDECINE INTERNE, 2008, 29 (11) :940-942
[16]   ANTIGRANULOCYTE OPSONIC ACTIVITY IN SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
HADLEY, AG ;
BYRON, MA ;
CHAPEL, HM ;
BUNCH, C ;
HOLBURN, AM .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (01) :61-65
[17]  
HARTMAN KR, 1991, BLOOD, V78, P1096
[18]  
Holland K, 1992, CLIN IMMUNOTOXICOLOG, P141
[19]  
HUIZINGA TWJ, 1990, BLOOD, V75, P213
[20]   Chronic mild neutropenia in adults:: relation to IgG3 deficiency and infection susceptibility [J].
Karlström, R ;
Gustafson, R ;
Palmblad, J .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (04) :342-347